KA
Klingman & Associates Portfolio holdings
AUM
$1.81B
1-Year Return
11.88%
This Quarter Return
+6.42%
1 Year Return
+11.88%
3 Year Return
+45.28%
5 Year Return
+77.09%
10 Year Return
+123.71%
AUM
$1.44B
AUM Growth
+$76.7M
(+5.6%)
Cap. Flow
-$54M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
51.42%
Holding
238
New
13
Increased
85
Reduced
73
Closed
1
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$3.45M |
| 2 |
Citizens Financial Group
CFG
|
$3.23M |
| 3 |
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
|
$2.98M |
| 4 |
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
|
$2.92M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$2.54M |
Top Sells
Sector Composition
| 1 | Technology | 6.12% |
| 2 | Financials | 3.66% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.77% |
| 5 | Real Estate | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Southern Company
SO
$101B
| $270K | 0.02% |
3,761
| – | – |
|
202
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$9.67B
| $268K | 0.02% |
2,296
| – | – |
|
203
GE HealthCare
GEHC
$33.8B
| $263K | 0.02% |
2,897
+38
| +1% | +$3.46K |
|
204
Novartis
NVS
$249B
| $263K | 0.02% |
2,715
| – | – |
|
205
Consolidated Edison
ED
$35.3B
| $258K | 0.02% |
2,839
+11
| +0.4% | +$999 |
|
206
Schwab US Dividend Equity ETF
SCHD
$71.9B
| $254K | 0.02% |
9,462
| – | – |
|
207
Philip Morris
PM
$251B
| $252K | 0.02% |
2,750
-12
| -0.4% | -$1.1K |
|
208
Starbucks
SBUX
$98.9B
| $252K | 0.02% |
2,754
+35
| +1% | +$3.2K |
|
209
Alliant Energy
LNT
$16.6B
| $249K | 0.02% |
4,945
| – | – |
|
210
BHP
BHP
$141B
| $248K | 0.02% |
4,306
+17
| +0.4% | +$981 |
|
211
Mondelez International
MDLZ
$78.8B
| $246K | 0.02% |
3,513
| – | – |
|
212
Qualcomm
QCOM
$172B
| $245K | 0.02% |
1,446
+3
| +0.2% | +$508 |
|
213
iShares Russell 2000 Growth ETF
IWO
$12.4B
| $244K | 0.02% |
902
| – | – |
|
214
iShares Core S&P US Value ETF
IUSV
$22.1B
| $243K | 0.02% |
2,690
| – | – |
|
215
CarMax
KMX
$9.15B
| $243K | 0.02% |
2,785
| – | – |
|
216
Regeneron Pharmaceuticals
REGN
$60.1B
| $242K | 0.02% |
251
+4
| +2% | +$3.85K |
|
217
Caterpillar
CAT
$197B
| $237K | 0.02% |
+648
| New | +$237K |
|
218
Rio Tinto
RIO
$101B
| $237K | 0.02% |
3,724
| – | – |
|
219
Pfizer
PFE
$140B
| $233K | 0.02% |
8,379
-3,717
| -31% | -$103K |
|
220
Novo Nordisk
NVO
$249B
| $230K | 0.02% |
+1,792
| New | +$230K |
|
221
The Greenbrier Companies
GBX
$1.45B
| $229K | 0.02% |
+4,400
| New | +$229K |
|
222
J.M. Smucker
SJM
$12B
| $227K | 0.02% |
1,803
-3
| -0.2% | -$378 |
|
223
Parker-Hannifin
PH
$95.9B
| $226K | 0.02% |
+407
| New | +$226K |
|
224
Broadstone Net Lease
BNL
$3.5B
| $224K | 0.02% |
14,288
| – | – |
|
225
Cognizant
CTSH
$34.9B
| $212K | 0.01% |
+2,895
| New | +$212K |
|